Adherence to antiepileptic drugs among children attending a tertiary health unit in a low resource setting

Rose Nazziwa1, Angelina Kakooza Mwesige1, Celestino Obua2

  • 1Department of Pediatrics and Child Health, College of Health Sciences, Makerere University.

Insights

In Uganda, most children with epilepsy showed good adherence to antiepileptic drugs based on self-reporting. However, caregiver employment was linked to increased non-adherence, highlighting a critical factor in treatment success.

Area of Science:

  • Pediatric Neurology
  • Public Health
  • Pharmacology

Background:

  • Epilepsy affects 70 million globally, with a 13% prevalence in Uganda.
  • Uganda faces challenges in understanding antiepileptic drug adherence among children.
  • This study addresses the gap in knowledge regarding adherence and its influencing factors in Ugandan children with epilepsy.

Purpose of the Study:

  • To determine antiepileptic drug adherence levels in Ugandan children.
  • To identify factors associated with non-adherence to antiepileptic drugs in this population.

Main Methods:

  • A cross-sectional study involving 122 children diagnosed with epilepsy.
  • Adherence assessed via self-report and serum drug level assays.
  • Focus group discussions explored factors influencing adherence.

Main Results:

  • Self-reported adherence was 79.5%, while serum drug levels indicated 22.1% adherence.
  • A significant proportion (95/122) of children had inadequate drug doses.
  • Caregiver employment was associated with increased likelihood of non-adherence (p=0.030).

Conclusions:

  • Self-reported adherence suggests a majority of children comply with treatment.
  • Caregiver occupation emerged as a significant risk factor for non-adherence.
  • Findings highlight the need for tailored interventions considering socioeconomic factors.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
400
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
547
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
2.3K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
954
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
1.0K